in fact , hmg coa reductase inhibitors may be the drugs of choice for niddm patients with elevated ldl cholesterol and borderline hypertriglyceridemia , whereas gemfibrozil appears preferable for niddm patients with severe hypertriglyceridemia .
C0017245
gemfibrozil
C0020557
hypertriglyceridemia